Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine

OBJECTIVE Myocardial depression from verapamil toxicity may result from alterations in carbohydrate metabolism as well as calcium-channel antagonism. We hypothesized that pharmacologic doses of insulin may be effective in reversing both of these deficits. DESIGN Randomized, controlled, prospective s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Critical care medicine 1995-07, Vol.23 (7), p.1251-1263
Hauptverfasser: Kline, Jeffrey A, Leonova, Elena, Raymond, Richard M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1263
container_issue 7
container_start_page 1251
container_title Critical care medicine
container_volume 23
creator Kline, Jeffrey A
Leonova, Elena
Raymond, Richard M
description OBJECTIVE Myocardial depression from verapamil toxicity may result from alterations in carbohydrate metabolism as well as calcium-channel antagonism. We hypothesized that pharmacologic doses of insulin may be effective in reversing both of these deficits. DESIGN Randomized, controlled, prospective study. SETTING Laboratory of an urban hospital. SUBJECTS Thirty mongrel dogs. INTERVENTIONS Thirty mongrel canines were anesthetized with alpha-chloralose. Toxicity was induced by the administration of 0.1 mg/kg/min iv of verapamil, until there was a 50% reduction in mean arterial pressure, for 30 mins (titration), followed by a continuous verapamil infusion of 1 mg/kg/hr. Animals (n = 6 per group) were randomized to the control group (saline only) or to one of four treatment protocolsa) calcium chloride (20 mg/kg), then 0.6 mg/kg/hr; b) hyperinsulinemia-euglycemia (4.0 U/min of recombinant insulin, with arterial glucose concentration clamped to +/-10 mg/dL [+/-0.5 mmol/L] of the basal value); c) epinephrine, with a starting rate of 1.0 micro gram/kg/min, titrated to maintain left ventricular pressure at basal values; or d) glucagon, a 0.2-mg/kg bolus, followed by a 150-micro gram/kg/hr infusion. Animals were monitored until death or 240 mins; infusate volumes were held constant for all groups. MEASUREMENTS AND MAIN RESULTS During verapamil titration, the myocardial respiratory quotient increased from 0.84 +/- 0.05 to 1.07 +/- 0.11 (p < .05, paired t-test) and myocardial glucose uptake doubled, despite a reduction in cardiac work (p < .05, paired t-test). Net myocardial lactate uptake also increased significantly, excluding myocardial ischemia. In controls, this trend continued, indicating preferential carbohydrate metabolism during untreated verapamil toxicity. Despite hyperglycemia, the plasma insulin concentration was not significantly different in controls (basal value 11 +/- 2 vs. 39 +/- 21 mu U/mL at 30 mins). Hyperinsulinemia-euglycemia increased both myocardial glucose and lactate uptake five-fold, and significantly increased the ratio of myocardial oxygen delivery/work, along with superior improvements in maximal left ventricular elastance at end systole compared with other treatments (p < .05 vs. other treatments, contrast analysis). CONCLUSIONS Verapamil toxicity renders the heart dependent on carbohydrate metabolism. Inasmuch as the positive inotropic effects of all treatments were coincident with increased indices of myocardial carbohydrate uptake, a
doi_str_mv 10.1097/00003246-199507000-00016
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00003246_199507000_00016</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>7600835</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3846-aecfae75bb5bd0f30e592287e1b18cf33fb39c4c44d7a62874af7cf7ebc6d7343</originalsourceid><addsrcrecordid>eNp1kctOwzAQRS0EKqXwCUhesA04HSdOllDxkpDYwDqaOOPW4CaVnVLK1-M-6A5L1szonjuSrxnjqbhORaluRDwwlnmSlmUmVJySeNP8iA3TDOIwLuGYDYUoRQKyhFN2FsJHJGSmYMAGKheigGzIpnfUkrHaouPzdafRN9uWeqw7ZzUnY0j3gXeG2zYsnW15s_S2nfIv8rjAuXW8777jhn4dCd7PiGNLIdbe_lDDNba2pXN2YtAFutjXEXt_uH-bPCUvr4_Pk9uXREMRn4OkDZLK6jqrG2FAUFaOx4WitE4LbQBMDaWWWspGYR4FiUZpo6jWeaNAwogVu73adyF4MtXC2zn6dZWKahNd9RdddYiu2kYXrZc762JZz6k5GPdZRf1qr2PQ6IzHVttwwCArCig2mNxhq8715MOnW67IVzNC18-q_z4OfgFaA4iO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Kline, Jeffrey A ; Leonova, Elena ; Raymond, Richard M</creator><creatorcontrib>Kline, Jeffrey A ; Leonova, Elena ; Raymond, Richard M</creatorcontrib><description>OBJECTIVE Myocardial depression from verapamil toxicity may result from alterations in carbohydrate metabolism as well as calcium-channel antagonism. We hypothesized that pharmacologic doses of insulin may be effective in reversing both of these deficits. DESIGN Randomized, controlled, prospective study. SETTING Laboratory of an urban hospital. SUBJECTS Thirty mongrel dogs. INTERVENTIONS Thirty mongrel canines were anesthetized with alpha-chloralose. Toxicity was induced by the administration of 0.1 mg/kg/min iv of verapamil, until there was a 50% reduction in mean arterial pressure, for 30 mins (titration), followed by a continuous verapamil infusion of 1 mg/kg/hr. Animals (n = 6 per group) were randomized to the control group (saline only) or to one of four treatment protocolsa) calcium chloride (20 mg/kg), then 0.6 mg/kg/hr; b) hyperinsulinemia-euglycemia (4.0 U/min of recombinant insulin, with arterial glucose concentration clamped to +/-10 mg/dL [+/-0.5 mmol/L] of the basal value); c) epinephrine, with a starting rate of 1.0 micro gram/kg/min, titrated to maintain left ventricular pressure at basal values; or d) glucagon, a 0.2-mg/kg bolus, followed by a 150-micro gram/kg/hr infusion. Animals were monitored until death or 240 mins; infusate volumes were held constant for all groups. MEASUREMENTS AND MAIN RESULTS During verapamil titration, the myocardial respiratory quotient increased from 0.84 +/- 0.05 to 1.07 +/- 0.11 (p &lt; .05, paired t-test) and myocardial glucose uptake doubled, despite a reduction in cardiac work (p &lt; .05, paired t-test). Net myocardial lactate uptake also increased significantly, excluding myocardial ischemia. In controls, this trend continued, indicating preferential carbohydrate metabolism during untreated verapamil toxicity. Despite hyperglycemia, the plasma insulin concentration was not significantly different in controls (basal value 11 +/- 2 vs. 39 +/- 21 mu U/mL at 30 mins). Hyperinsulinemia-euglycemia increased both myocardial glucose and lactate uptake five-fold, and significantly increased the ratio of myocardial oxygen delivery/work, along with superior improvements in maximal left ventricular elastance at end systole compared with other treatments (p &lt; .05 vs. other treatments, contrast analysis). CONCLUSIONS Verapamil toxicity renders the heart dependent on carbohydrate metabolism. Inasmuch as the positive inotropic effects of all treatments were coincident with increased indices of myocardial carbohydrate uptake, adequate treatment of verapamil toxicity appeared to require maximal myocardial carbohydrate utilization. Hyperinsulinemia-euglycemia allows larger increases in myocardial carbohydrate metabolism and myocardial contractility than calcium chloride, epinephrine, or glucagon, resulting in improved survival rates during severe verapamil toxicity.(Crit Care Med 1995; 23:1251-1263)</description><identifier>ISSN: 0090-3493</identifier><identifier>EISSN: 1530-0293</identifier><identifier>DOI: 10.1097/00003246-199507000-00016</identifier><identifier>PMID: 7600835</identifier><identifier>CODEN: CCMDC7</identifier><language>eng</language><publisher>Hagerstown, MD: Williams &amp; Wilkins</publisher><subject>Anesthesia, Intravenous ; Animals ; Antidotes - therapeutic use ; Biological and medical sciences ; Dogs ; Drug Evaluation, Preclinical ; Drug toxicity and drugs side effects treatment ; Female ; Heart - drug effects ; Hemodynamics - drug effects ; Insulin - therapeutic use ; Male ; Medical sciences ; Myocardium - metabolism ; Oxygen Consumption - drug effects ; Pharmacology. Drug treatments ; Poisoning - drug therapy ; Poisoning - metabolism ; Poisoning - physiopathology ; Prospective Studies ; Random Allocation ; Time Factors ; Toxicity: cardiovascular system ; Verapamil - poisoning ; Verapamil - toxicity</subject><ispartof>Critical care medicine, 1995-07, Vol.23 (7), p.1251-1263</ispartof><rights>Williams &amp; Wilkins 1995. All Rights Reserved.</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3846-aecfae75bb5bd0f30e592287e1b18cf33fb39c4c44d7a62874af7cf7ebc6d7343</citedby><cites>FETCH-LOGICAL-c3846-aecfae75bb5bd0f30e592287e1b18cf33fb39c4c44d7a62874af7cf7ebc6d7343</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3588385$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7600835$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kline, Jeffrey A</creatorcontrib><creatorcontrib>Leonova, Elena</creatorcontrib><creatorcontrib>Raymond, Richard M</creatorcontrib><title>Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine</title><title>Critical care medicine</title><addtitle>Crit Care Med</addtitle><description>OBJECTIVE Myocardial depression from verapamil toxicity may result from alterations in carbohydrate metabolism as well as calcium-channel antagonism. We hypothesized that pharmacologic doses of insulin may be effective in reversing both of these deficits. DESIGN Randomized, controlled, prospective study. SETTING Laboratory of an urban hospital. SUBJECTS Thirty mongrel dogs. INTERVENTIONS Thirty mongrel canines were anesthetized with alpha-chloralose. Toxicity was induced by the administration of 0.1 mg/kg/min iv of verapamil, until there was a 50% reduction in mean arterial pressure, for 30 mins (titration), followed by a continuous verapamil infusion of 1 mg/kg/hr. Animals (n = 6 per group) were randomized to the control group (saline only) or to one of four treatment protocolsa) calcium chloride (20 mg/kg), then 0.6 mg/kg/hr; b) hyperinsulinemia-euglycemia (4.0 U/min of recombinant insulin, with arterial glucose concentration clamped to +/-10 mg/dL [+/-0.5 mmol/L] of the basal value); c) epinephrine, with a starting rate of 1.0 micro gram/kg/min, titrated to maintain left ventricular pressure at basal values; or d) glucagon, a 0.2-mg/kg bolus, followed by a 150-micro gram/kg/hr infusion. Animals were monitored until death or 240 mins; infusate volumes were held constant for all groups. MEASUREMENTS AND MAIN RESULTS During verapamil titration, the myocardial respiratory quotient increased from 0.84 +/- 0.05 to 1.07 +/- 0.11 (p &lt; .05, paired t-test) and myocardial glucose uptake doubled, despite a reduction in cardiac work (p &lt; .05, paired t-test). Net myocardial lactate uptake also increased significantly, excluding myocardial ischemia. In controls, this trend continued, indicating preferential carbohydrate metabolism during untreated verapamil toxicity. Despite hyperglycemia, the plasma insulin concentration was not significantly different in controls (basal value 11 +/- 2 vs. 39 +/- 21 mu U/mL at 30 mins). Hyperinsulinemia-euglycemia increased both myocardial glucose and lactate uptake five-fold, and significantly increased the ratio of myocardial oxygen delivery/work, along with superior improvements in maximal left ventricular elastance at end systole compared with other treatments (p &lt; .05 vs. other treatments, contrast analysis). CONCLUSIONS Verapamil toxicity renders the heart dependent on carbohydrate metabolism. Inasmuch as the positive inotropic effects of all treatments were coincident with increased indices of myocardial carbohydrate uptake, adequate treatment of verapamil toxicity appeared to require maximal myocardial carbohydrate utilization. Hyperinsulinemia-euglycemia allows larger increases in myocardial carbohydrate metabolism and myocardial contractility than calcium chloride, epinephrine, or glucagon, resulting in improved survival rates during severe verapamil toxicity.(Crit Care Med 1995; 23:1251-1263)</description><subject>Anesthesia, Intravenous</subject><subject>Animals</subject><subject>Antidotes - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Dogs</subject><subject>Drug Evaluation, Preclinical</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Female</subject><subject>Heart - drug effects</subject><subject>Hemodynamics - drug effects</subject><subject>Insulin - therapeutic use</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Myocardium - metabolism</subject><subject>Oxygen Consumption - drug effects</subject><subject>Pharmacology. Drug treatments</subject><subject>Poisoning - drug therapy</subject><subject>Poisoning - metabolism</subject><subject>Poisoning - physiopathology</subject><subject>Prospective Studies</subject><subject>Random Allocation</subject><subject>Time Factors</subject><subject>Toxicity: cardiovascular system</subject><subject>Verapamil - poisoning</subject><subject>Verapamil - toxicity</subject><issn>0090-3493</issn><issn>1530-0293</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kctOwzAQRS0EKqXwCUhesA04HSdOllDxkpDYwDqaOOPW4CaVnVLK1-M-6A5L1szonjuSrxnjqbhORaluRDwwlnmSlmUmVJySeNP8iA3TDOIwLuGYDYUoRQKyhFN2FsJHJGSmYMAGKheigGzIpnfUkrHaouPzdafRN9uWeqw7ZzUnY0j3gXeG2zYsnW15s_S2nfIv8rjAuXW8777jhn4dCd7PiGNLIdbe_lDDNba2pXN2YtAFutjXEXt_uH-bPCUvr4_Pk9uXREMRn4OkDZLK6jqrG2FAUFaOx4WitE4LbQBMDaWWWspGYR4FiUZpo6jWeaNAwogVu73adyF4MtXC2zn6dZWKahNd9RdddYiu2kYXrZc762JZz6k5GPdZRf1qr2PQ6IzHVttwwCArCig2mNxhq8715MOnW67IVzNC18-q_z4OfgFaA4iO</recordid><startdate>199507</startdate><enddate>199507</enddate><creator>Kline, Jeffrey A</creator><creator>Leonova, Elena</creator><creator>Raymond, Richard M</creator><general>Williams &amp; Wilkins</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>199507</creationdate><title>Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine</title><author>Kline, Jeffrey A ; Leonova, Elena ; Raymond, Richard M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3846-aecfae75bb5bd0f30e592287e1b18cf33fb39c4c44d7a62874af7cf7ebc6d7343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Anesthesia, Intravenous</topic><topic>Animals</topic><topic>Antidotes - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Dogs</topic><topic>Drug Evaluation, Preclinical</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Female</topic><topic>Heart - drug effects</topic><topic>Hemodynamics - drug effects</topic><topic>Insulin - therapeutic use</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Myocardium - metabolism</topic><topic>Oxygen Consumption - drug effects</topic><topic>Pharmacology. Drug treatments</topic><topic>Poisoning - drug therapy</topic><topic>Poisoning - metabolism</topic><topic>Poisoning - physiopathology</topic><topic>Prospective Studies</topic><topic>Random Allocation</topic><topic>Time Factors</topic><topic>Toxicity: cardiovascular system</topic><topic>Verapamil - poisoning</topic><topic>Verapamil - toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kline, Jeffrey A</creatorcontrib><creatorcontrib>Leonova, Elena</creatorcontrib><creatorcontrib>Raymond, Richard M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kline, Jeffrey A</au><au>Leonova, Elena</au><au>Raymond, Richard M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine</atitle><jtitle>Critical care medicine</jtitle><addtitle>Crit Care Med</addtitle><date>1995-07</date><risdate>1995</risdate><volume>23</volume><issue>7</issue><spage>1251</spage><epage>1263</epage><pages>1251-1263</pages><issn>0090-3493</issn><eissn>1530-0293</eissn><coden>CCMDC7</coden><abstract>OBJECTIVE Myocardial depression from verapamil toxicity may result from alterations in carbohydrate metabolism as well as calcium-channel antagonism. We hypothesized that pharmacologic doses of insulin may be effective in reversing both of these deficits. DESIGN Randomized, controlled, prospective study. SETTING Laboratory of an urban hospital. SUBJECTS Thirty mongrel dogs. INTERVENTIONS Thirty mongrel canines were anesthetized with alpha-chloralose. Toxicity was induced by the administration of 0.1 mg/kg/min iv of verapamil, until there was a 50% reduction in mean arterial pressure, for 30 mins (titration), followed by a continuous verapamil infusion of 1 mg/kg/hr. Animals (n = 6 per group) were randomized to the control group (saline only) or to one of four treatment protocolsa) calcium chloride (20 mg/kg), then 0.6 mg/kg/hr; b) hyperinsulinemia-euglycemia (4.0 U/min of recombinant insulin, with arterial glucose concentration clamped to +/-10 mg/dL [+/-0.5 mmol/L] of the basal value); c) epinephrine, with a starting rate of 1.0 micro gram/kg/min, titrated to maintain left ventricular pressure at basal values; or d) glucagon, a 0.2-mg/kg bolus, followed by a 150-micro gram/kg/hr infusion. Animals were monitored until death or 240 mins; infusate volumes were held constant for all groups. MEASUREMENTS AND MAIN RESULTS During verapamil titration, the myocardial respiratory quotient increased from 0.84 +/- 0.05 to 1.07 +/- 0.11 (p &lt; .05, paired t-test) and myocardial glucose uptake doubled, despite a reduction in cardiac work (p &lt; .05, paired t-test). Net myocardial lactate uptake also increased significantly, excluding myocardial ischemia. In controls, this trend continued, indicating preferential carbohydrate metabolism during untreated verapamil toxicity. Despite hyperglycemia, the plasma insulin concentration was not significantly different in controls (basal value 11 +/- 2 vs. 39 +/- 21 mu U/mL at 30 mins). Hyperinsulinemia-euglycemia increased both myocardial glucose and lactate uptake five-fold, and significantly increased the ratio of myocardial oxygen delivery/work, along with superior improvements in maximal left ventricular elastance at end systole compared with other treatments (p &lt; .05 vs. other treatments, contrast analysis). CONCLUSIONS Verapamil toxicity renders the heart dependent on carbohydrate metabolism. Inasmuch as the positive inotropic effects of all treatments were coincident with increased indices of myocardial carbohydrate uptake, adequate treatment of verapamil toxicity appeared to require maximal myocardial carbohydrate utilization. Hyperinsulinemia-euglycemia allows larger increases in myocardial carbohydrate metabolism and myocardial contractility than calcium chloride, epinephrine, or glucagon, resulting in improved survival rates during severe verapamil toxicity.(Crit Care Med 1995; 23:1251-1263)</abstract><cop>Hagerstown, MD</cop><pub>Williams &amp; Wilkins</pub><pmid>7600835</pmid><doi>10.1097/00003246-199507000-00016</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0090-3493
ispartof Critical care medicine, 1995-07, Vol.23 (7), p.1251-1263
issn 0090-3493
1530-0293
language eng
recordid cdi_crossref_primary_10_1097_00003246_199507000_00016
source MEDLINE; Journals@Ovid Complete
subjects Anesthesia, Intravenous
Animals
Antidotes - therapeutic use
Biological and medical sciences
Dogs
Drug Evaluation, Preclinical
Drug toxicity and drugs side effects treatment
Female
Heart - drug effects
Hemodynamics - drug effects
Insulin - therapeutic use
Male
Medical sciences
Myocardium - metabolism
Oxygen Consumption - drug effects
Pharmacology. Drug treatments
Poisoning - drug therapy
Poisoning - metabolism
Poisoning - physiopathology
Prospective Studies
Random Allocation
Time Factors
Toxicity: cardiovascular system
Verapamil - poisoning
Verapamil - toxicity
title Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T01%3A57%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Beneficial%20myocardial%20metabolic%20effects%20of%20insulin%20during%20verapamil%20toxicity%20in%20the%20anesthetized%20canine&rft.jtitle=Critical%20care%20medicine&rft.au=Kline,%20Jeffrey%20A&rft.date=1995-07&rft.volume=23&rft.issue=7&rft.spage=1251&rft.epage=1263&rft.pages=1251-1263&rft.issn=0090-3493&rft.eissn=1530-0293&rft.coden=CCMDC7&rft_id=info:doi/10.1097/00003246-199507000-00016&rft_dat=%3Cpubmed_cross%3E7600835%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/7600835&rfr_iscdi=true